CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$247,000
-18.5%
102,8000.0%0.00%
Q4 2020$303,000
+93.0%
102,8000.0%0.00%
Q3 2020$157,000
-38.9%
102,8000.0%0.00%
Q2 2020$257,000
+21.2%
102,800
-1.3%
0.00%
Q1 2020$212,000
-46.5%
104,118
-18.7%
0.00%
Q4 2019$396,000
-14.3%
128,018
-7.4%
0.00%
Q3 2019$462,000
+3.4%
138,318
-0.9%
0.00%
-100.0%
Q2 2019$447,000
+11.5%
139,6000.0%0.00%
Q1 2019$401,000
-28.5%
139,6000.0%0.00%
-100.0%
Q4 2018$561,000
-38.4%
139,600
-28.4%
0.00%0.0%
Q3 2018$910,000
-19.0%
194,945
+42.8%
0.00%
-50.0%
Q2 2018$1,124,000
+97.5%
136,5180.0%0.00%
+100.0%
Q1 2018$569,000
+28.2%
136,5180.0%0.00%0.0%
Q4 2017$444,000
+83.5%
136,5180.0%0.00%
Q3 2017$242,000
+69.2%
136,5180.0%0.00%
Q2 2017$143,000
-26.3%
136,5180.0%0.00%
Q1 2017$194,000
+23.6%
136,5180.0%0.00%
Q4 2016$157,000
+3.3%
136,5180.0%0.00%
Q3 2016$152,000
-5.0%
136,5180.0%0.00%
Q2 2016$160,000
+10.3%
136,5180.0%0.00%
Q1 2016$145,000
+10.7%
136,5180.0%0.00%
Q4 2015$131,000
-10.3%
136,5180.0%0.00%
Q3 2015$146,000
-40.2%
136,5180.0%0.00%
Q2 2015$244,000
+6.6%
136,5180.0%0.00%
Q1 2015$229,0000.0%136,5180.0%0.00%
Q4 2014$229,000
-6.1%
136,5180.0%0.00%
Q3 2014$244,000136,5180.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders